“EXPLORING THE ADHERENCE TO ORAL ANTIDIABETIC MEDICATIONS AMONG TYPE 2 DM PATIENTS IN DISTRICT GUJRAT: A CROSS-SECTIONAL STUDY”
Main Article Content
Keywords
Diabetes type II, Medication adherence, glycemic control, patient compliance
Abstract
Diabetes is a chronic, non-communicable disease that mostly affects adults as Type 2 diabetes. It is caused by inadequate insulin usage, which raises blood glucose levels. With rising urbanization in developing nations, the prevalence has risen to 537 million worldwide and is expected to reach 783 million by 2045. Because Type 2 diabetes is more prone to cause microvascular and macrovascular complications, it is imperative to manage concomitant diseases and maintain rigorous glycemic control. In order to reduce morbidity and death, strict adherence to regimens that include medication, dietary changes, and glucose monitoring is essential.
For diabetic patients, family support plays a critical role in determining medication compliance and glycemic control. Care services and emotional well-being are impacted by patients' perceptions of family support. It is unknown how social support affects glycemic control. Globally, Pakistan has the highest rate of diabetes (30.8% in 2023).
1.2. Aims
Using the Morisky medication adherence scale (MMAS-8), a study conducted in Gujrat, Pakistan, aimed to evaluate medication adherence and its relationship to family support among diabetic patients.
1.3. Objective
To Unveil the relationship between family support, medication adherence and glycemic control in diabetes type II patients of district Gujrat.
1.4. Methodology
Survey was questionnaire based. Questions were related to patient’s demographics, diabetic history and medication adherence using MMAS-8 scale. A total of 330 patients, who were above 18, were included in the study. Data was analyzed to investigate the connection between glycemic control and medication adherence.
1.5. Result
330 patients in total had been included in the survey. The survey revealed a relatively high prevalence of medication non-adherence, which led to poor glycemic control. Patients who were > 49 and had complex treatment regimens were more likely to be non-adherencers. The most common reasons given by patients for their nonadherence were forgetfulness (54.58%), carelessness (47.42%), and treatment regimen complexity (52.92%).
1.6. Conclusion
Medication adherence was less owing to the complexity of medication adherence and forgetfulness. Medication non-adherence resulted in poor glycemic control.
References
2. Al-Qazaz, H. K., Hassali, M. A., Shafie, A. A., Sulaiman, S. A., Sundram, S., & Morisky, D. E. (2010). The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes research and clinical practice, 90(2), 216221.
3. Al-Qazaz, H. K., Sulaiman, S. A., Hassali, M. A., Shafie, A. A., Sundram, S., Al-Nuri, R., & Saleem, F. (2011). Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. International journal of clinical pharmacy, 33, 1028-1035.
4. Aminde, L. N., Tindong, M., Ngwasiri, C. A., Aminde, J. A., Njim, T., Fondong, A. A., & Takah, N. F. (2019). Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC endocrine disorders, 19, 1-9.
5. Bezie, Y., Molina, M., Hernandez, N., Batista, R., Niang, S., & Huet, D. (2006). Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes & metabolism, 32(6), 611-616.
6. Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Bärnighausen, T., & Vollmer, S. (2017). The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. The lancet Diabetes & endocrinology, 5(6), 423-430.
7. CDC. (2024). National Diabetes Statistics Report. https://www.cdc.gov/diabetes/php/dataresearch/?CDC_AAref_Val=https://www.cdc.gov/diabetes/data/statisticsreport/index.html
8. Egede, L. E., Gebregziabher, M., Dismuke, C. E., Lynch, C. P., Axon, R. N., Zhao, Y., & Mauldin, P. D. (2012). Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes care, 35(12), 2533-2539.
9. Federation, I. D. (2023). Diabetes Facts and Figures. https://idf.org/about-diabetes/diabetesfacts-figures/
10. Gherman, A., Schnur, J., Montgomery, G., Sassu, R., Veresiu, I., & David, D. (2011). How are adherent people more likely to think? A meta-analysis of health beliefs and diabetes selfcare. The Diabetes Educator, 37(3), 392-408.
11. Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006). Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of internal medicine, 166(17), 18361841.
12. Iloh, G., Collins, P. I., & Amadi, A. N. (2018). Family functionality, medication adherence, and blood glucose control among ambulatory type 2 diabetic patients in a primary care clinic in Nigeria. Int J Health Allied Sci, 7(1), 23-30.
13. Krapek, K., King, K., Warren, S. S., George, K. G., Caputo, D. A., Mihelich, K., Holst, E. M., Nichol, M. B., Shi, S. G., & Livengood, K. B. (2004). Medication adherence and associated hemoglobin A1c in type 2 diabetes. Annals of Pharmacotherapy, 38(9), 13571362.
14. Lin, L.-K., Sun, Y., Heng, B. H., Chew, D. E. K., & Chong, P.-N. (2017). Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Research and Care, 5(1), e000429.
15. Magliano, D. J., Boyko, E. J., & Atlas, I. D. (2021). What is diabetes? In IDF DIABETES ATLAS [Internet]. 10th edition. International Diabetes Federation.
16. Misra, A., Gopalan, H., Jayawardena, R., Hills, A. P., Soares, M., Reza‐Albarrán, A. A., & Ramaiya, K. L. (2019). Diabetes in developing countries. Journal of diabetes, 11(7), 522539.
17. Nazimek-Siewniak, B., Moczulski, D., & Grzeszczak, W. (2002). Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design. Journal of Diabetes and its Complications, 16(4), 271-276.
18. Olickal, J. J., Chinnakali, P., Suryanarayana, B., Saya, G. K., Ganapathy, K., & Subrahmanyam, D. (2021). Medication adherence and glycemic control status among people with diabetes seeking care from a tertiary care teaching hospital, south India. Clinical Epidemiology and Global Health, 11, 100742.
19. Organization, W. H. Diabetes. https://www.who.int/health-topics/diabetes#tab=tab_1
20. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England journal of medicine, 353(5), 487-497.
21. Rhee, M. K., Slocum, W., Ziemer, D. C., Culler, S. D., Cook, C. B., El-Kebbi, I. M., Gallina, D. L., Barnes, C., & Phillips, L. S. (2005). Patient adherence improves glycemic control. The Diabetes Educator, 31(2), 240-250.
22. Saaddine, J. B., Engelgau, M. M., Beckles, G. L., Gregg, E. W., Thompson, T. J., & Narayan, K. V. (2002). A diabetes report card for the United States: quality of care in the 1990s. Annals of internal medicine, 136(8), 565-574.
23. Sendekie, A. K., Netere, A. K., Kasahun, A. E., & Belachew, E. A. (2022). Medication adherence and its impact on glycemic control in type 2 diabetes mellitus patients with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia. Plos one, 17(9), e0274971.
24. Stratton, I. M., Adler, A. I., Neil, H. A. W., Matthews, D. R., Manley, S. E., Cull, C. A., Hadden, D., Turner, R. C., & Holman, R. R. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj, 321(7258), 405-412.
25. Suprapti, B., Izzah, Z., Anjani, A. G., Andarsari, M. R., Nilamsari, W. P., & Nugroho, C. W. (2023). Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study. Global Epidemiology, 5, 100113.
26. Vasudevan, A. R., Burns, A., & Fonseca, V. A. (2006). The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus. Treatments in endocrinology, 5, 273-286.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Wajiha Noor
Department of pharmacy, University of Lahore.
Aneesa Ejaz
Department of Pharmacy, University of Lahore.
Ukasha Ehsan
Department of Pharmacy, University of Lahore.
Eman Chaudhary
Department of pharmacy, University of Lahore.
Isha Asim Jarral
Department of pharmacy, University of Lahore.